anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Title

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 303,780
Current window 224,071-224,100
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all
18 30 60

Component

224,071-224,100 of 303,780

filter-aware
03
Slide 3 of an LVMH presentation.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · Attention1 hit
05
The slide highlights a total revenue of 62.2 billion Euros.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · Need1 hit
06
The chart displays 5 regions/groups, each with 4 bars representing Q1, Q2, Q3, and 9M 2023.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · Need1 hit
07
The chart uses a grouped bar structure within vertical panels for each division.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · Need1 hit
08
The slide uses a high-fashion photograph (likely Louis Vuitton) as a background, typical of luxury brand corporate presentations.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction1 hit
11
LVMH | Results Presentation Deck | 29 slidesLVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
14
LVMH | Results Presentation Deck | 29 slidesLVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
17
The slide uses a brand-by-brand breakdown to illustrate business momentum.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
20
LVMH | Results Presentation Deck | 29 slidesLVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
23
LVMH | Results Presentation Deck | 29 slidesLVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
24
This appears to be a placeholder or transition slide in a presentation deck, using a Louis Vuitton brand image.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · Action1 hit
25
The slide uses circular imagery of models in front of the Eiffel Tower to anchor four key strategic pillars.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · Action1 hit
26
The slide uses a high-fashion photography aesthetic typical of luxury brand presentations.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations 1 hit
27
LVMH | Results Presentation Deck | 29 slidesLVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations 1 hit
28
The table displays 60 distinct data points representing organic revenue growth percentages.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations 1 hit
29
The table includes two distinct blocks for 2023 and 2022, showing quarterly, half-year (H1), and nine-month (9M) figures.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations 1 hit
01
Slide 1
The background image depicts chromosomes, reinforcing the telomere-targeting focus.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
02
MAIA Biotechnology | Investor Presentation Deck | 39 slidesMAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
03
MAIA Biotechnology | Investor Presentation Deck | 39 slidesMAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
04
The slide outlines the status of THIO-101, 102, and 103 trials and mentions specific patent filings.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style layout to map drug candidates against clinical development stages.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Problem1 hit
06
The slide uses a chromosome icon for the lead asset and a fast-forward icon for the pipeline strategy.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Problem1 hit
07
MAIA Biotechnology | Investor Presentation Deck | 39 slidesMAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Solution1 hit
09
This slide serves as a transition or key message reinforcement.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Pattern Hunter1 hit
10
The slide uses a visual comparison between telomere targeting (left) and PD-1/PD-L1 checkpoint inhibition (right).MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Pattern Hunter1 hit
11
Slide highlights a strategic partnership/supply agreement as a form of business traction.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pattern Hunter1 hit
12
The chart shows tumor volume over time, highlighting the efficacy of the THIO + Atezo combination compared to controls.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pattern Hunter1 hit
13
The slide outlines a clinical trial process flow including randomization and expansion phases.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pattern Hunter1 hit
14
The table compares Cyramza+Docetaxel, Docetaxel alone, and THIO+Libtayo.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pattern Hunter1 hit
15
The slide highlights that THIO has a better safety profile than standard chemotherapy, which typically has 70-80% incidence of Grade 3-5 side effects.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit